MDM2 is a useful prognostic biomarker for resectable gastric cancer.
Ye Y, Li X, Yang J, Miao S, Wang S, Chen Y, Xia X, Wu X, Zhang J, Zhou Y, He S, Tan Y, Qiang F, Li G, Røe OD, Zhou J.
Ye Y, et al. Among authors: roe od.
Cancer Sci. 2013 May;104(5):590-8. doi: 10.1111/cas.12111. Epub 2013 Mar 5.
Cancer Sci. 2013.
PMID: 23347235
Free PMC article.